BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang HY, Xu WQ, Wang YW, Omari-Siaw E, Wang Y, Zheng YY, Cao X, Tong SS, Yu JN, Xu XM. Tumor targeted delivery of octreotide-periplogenin conjugate: Synthesis, in vitro and in vivo evaluation. Int J Pharm 2016;502:98-106. [PMID: 26899980 DOI: 10.1016/j.ijpharm.2016.02.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Chatzisideri T, Leonidis G, Sarli V. Cancer-targeted delivery systems based on peptides. Future Med Chem 2018;10:2201-26. [PMID: 30043641 DOI: 10.4155/fmc-2018-0174] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
2 Mahmoud AS, Abu Bakar MZ, Hamzah H, Tengkue Ahmad TA, Mohd Noor MH. Octreotide acetate enhanced radio sensitivity and induced apoptosis in MCF7 breast cancer cell line. Journal of Radiation Research and Applied Sciences 2022;15:193-8. [DOI: 10.1016/j.jrras.2022.01.008] [Reference Citation Analysis]
3 Karaś K, Sałkowska A, Dastych J, Bachorz RA, Ratajewski M. Cardiac glycosides with target at direct and indirect interactions with nuclear receptors. Biomed Pharmacother 2020;127:110106. [PMID: 32248001 DOI: 10.1016/j.biopha.2020.110106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li L, Wang Q, Zhang X, Luo L, He Y, Zhu R, Gao D. Dual-targeting liposomes for enhanced anticancer effect in somatostatin receptor II-positive tumor model. Nanomedicine 2018;13:2155-69. [DOI: 10.2217/nnm-2018-0115] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
5 Lei H, Xie M, Zhao Y, Zhang F, Xu Y, Xie J. Chitosan/sodium alginate modificated graphene oxide-based nanocomposite as a carrier for drug delivery. Ceramics International 2016;42:17798-805. [DOI: 10.1016/j.ceramint.2016.08.108] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
6 Song XL, Ju RJ, Xiao Y, Wang X, Liu S, Fu M, Liu JJ, Gu LY, Li XT, Cheng L. Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. Int J Nanomedicine 2017;12:7433-51. [PMID: 29066893 DOI: 10.2147/IJN.S141787] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
7 Zhu JJ, Zhang XX, Miao YQ, He SF, Tian DM, Yao XS, Tang JS, Gan Y. Delivery of acetylthevetin B, an antitumor cardiac glycoside, using polymeric micelles for enhanced therapeutic efficacy against lung cancer cells. Acta Pharmacol Sin 2017;38:290-300. [PMID: 27917871 DOI: 10.1038/aps.2016.113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
8 Vanza JD, Patel RB, Patel MR. Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer. Journal of Drug Delivery Science and Technology 2020;60:102070. [DOI: 10.1016/j.jddst.2020.102070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
9 Gote V, Pal D. Octreotide-Targeted Lcn2 siRNA PEGylated Liposomes as a Treatment for Metastatic Breast Cancer. Bioengineering (Basel) 2021;8:44. [PMID: 33916786 DOI: 10.3390/bioengineering8040044] [Reference Citation Analysis]
10 Zhang HY, Xu WQ, Zheng YY, Omari-Siaw E, Zhu Y, Cao X, Tong SS, Yu JN, Xu XM. Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation. Oncotarget 2016;7:86326-38. [PMID: 27861145 DOI: 10.18632/oncotarget.13389] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
11 Zhang H, Xu W, Omari-Siaw E, Liu Y, Chen B, Chen D, Yu J, Xu X. Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy. Drug Deliv 2017;24:1170-8. [PMID: 28835137 DOI: 10.1080/10717544.2017.1365393] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
12 Lin C, Li R, Huang C, Wei K, Chen P. Controlled release of liposome-encapsulated temozolomide for brain tumour treatment by convection-enhanced delivery. Journal of Drug Targeting 2018;26:325-32. [DOI: 10.1080/1061186x.2017.1379526] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
13 Xie M, Zhang F, Liu L, Zhang Y, Li Y, Li H, Xie J. Surface modification of graphene oxide nanosheets by protamine sulfate/sodium alginate for anti-cancer drug delivery application. Applied Surface Science 2018;440:853-60. [DOI: 10.1016/j.apsusc.2018.01.175] [Cited by in Crossref: 64] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
14 Chen H, Huang R, Li Z, Zhu W, Chen J, Zhan Y, Jiang B. Selective lysine modification of native peptides via aza-Michael addition. Org Biomol Chem 2017;15:7339-45. [DOI: 10.1039/c7ob01866e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
15 Li ZT, Zhang FX, Chen WW, Chen MH, Tang XY, Ye MN, Yao ZH, Yao XS, Dai Y. Characterization of chemical components of Periplocae Cortex and their metabolites in rats using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Biomed Chromatogr 2020;34:e4807. [PMID: 32020626 DOI: 10.1002/bmc.4807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ju RJ, Cheng L, Peng XM, Wang T, Li CQ, Song XL, Liu S, Chao JP, Li XT. Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer. Artif Cells Nanomed Biotechnol 2018;46:616-28. [PMID: 29381101 DOI: 10.1080/21691401.2018.1433187] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
17 Feng C, Rui M, Shen H, Xin Y, Zhang J, Li J, Yue L, Lai W, Xu X. Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer. International Journal of Pharmaceutics 2017;528:322-33. [DOI: 10.1016/j.ijpharm.2017.06.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
18 Feng C, Zhang H, Chen J, Wang S, Xin Y, Qu Y, Zhang Q, Ji W, Yamashita F, Rui M, Xu X. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer. Int J Pharm 2019;560:191-204. [PMID: 30769131 DOI: 10.1016/j.ijpharm.2019.02.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
19 Patel S. Plant-derived cardiac glycosides: Role in heart ailments and cancer management. Biomed Pharmacother 2016;84:1036-41. [PMID: 27780131 DOI: 10.1016/j.biopha.2016.10.030] [Cited by in Crossref: 64] [Cited by in F6Publishing: 48] [Article Influence: 10.7] [Reference Citation Analysis]
20 Zhang H, Zhu Y, Sun C, Xie Y, Adu-frimpong M, Deng W, Yu J, Xu X, Han Z, Qi G. GSH responsive nanomedicines self-assembled from small molecule prodrug alleviate the toxicity of cardiac glycosides as potent cancer drugs. International Journal of Pharmaceutics 2020;575:118980. [DOI: 10.1016/j.ijpharm.2019.118980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
21 Figueras E, Martins A, Borbély A, Le Joncour V, Cordella P, Perego R, Modena D, Pagani P, Esposito S, Auciello G, Frese M, Gallinari P, Laakkonen P, Steinkühler C, Sewald N. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics 2019;11:E220. [PMID: 31067748 DOI: 10.3390/pharmaceutics11050220] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Maria S, Sarwar HS, Sohail MF, Imran M, Salman Qureshi O, Raza A, Ahmad NM, Iqbal A, Shahnaz G. Synthesis and characterization of pre-activated thiolated chitosan nanoparticles for oral delivery of octreotide. Journal of Drug Delivery Science and Technology 2020;58:101807. [DOI: 10.1016/j.jddst.2020.101807] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
23 Mamat M, Wang X, Wu L, Zhao R, Cao J, Qi X, Shen S. CaO2/Fe3O4 nanocomposites for oxygen-independent generation of radicals and cancer therapy. Colloids Surf B Biointerfaces 2021;204:111803. [PMID: 33964529 DOI: 10.1016/j.colsurfb.2021.111803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]